The AI Eye: LG Electronics Unveils Four-Level AI Development Framework at CES and AI Metrics Partners with IQ-AI for Distribution
Point Roberts, WA and Vancouver, BC - January 17, 2020 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence.
Listen to the podcast:
The #AI Eye: LG Electronics Unveils Four-Level AI Development Framework at CES and AI Metrics Partners with IQ-AI for Distribution
Today's Column - The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence
Stocks discussed: (KSE:066570) (LSE:IQAI)
LG Electronics Inc. (KSE:066570) unveiled its new AI development framework at the CES 2020 LG Press Conference. The framework is composed of four levels - Efficiency, Personalization, Reasoning and Exploration - intended to "act as anchor points for the field of AI going forward." The first level, Efficiency, features AI that "can carry out specific functions through automation that make user interactions more efficient and effective," while the fourth and final level, Exploration, features AI that "is capable of original research, enough to formulate and test intelligent hypotheses to discover conclusions." Dr. I.P. Park, President and Chief Technology Officer of LG Electronics, commented:
"From Efficiency to Exploration, our vision for AI innovation is meaningful for both the industry and its customers. It enables and encourages us to come up with more daring, more innovative ideas for the future."
Early stage AI-powered radiology image analysis company AI Metrics has partnered with IQ-AI Limited (LSE:IQAI) to distribute the former's virtual liver biopsy software through the latter's subsidiary Imaging Biometrics. AI Metrics CEO Andrew Smith, commented:
"We are excited about partnering with Imaging Biometrics as we introduce LSN [liver surface nodularity] technology to the worldwide market. Their development efforts have been integral to bringing LSN from promising research to commercial introduction, and the continuity of our relationship moving forward will ensure that LSN can quickly gain widespread utilization."
AI in Life Sciences Market to Reach $3.445 Billion by 2025
A report from Research and Markets finds that the AI in Life Sciences market will grow from $1.092 billion in 2019 to $3.445 billion in 2025 with a compound annual growth rate (CAGR) of 21.1 percent in the forecast period. An excerpt from the report description outlines the role of clinical trials as a key market trend:
Clinical trials are one of the most data-intensive tasks in the life sciences industry. They generate vast sets of data every day monitoring several variables of a patient under observation. Subjecting these data sets to intelligent AI algorithms can help the researchers to screen meaningful correlation even between loosely coupled data.
This is encouraging many pharmaceutical companies and clinical research organizations to invest in technologies, like artificial intelligence. In the current market scenario, rapid adoption of AI is widely seen in the pharmaceutical sector, who are responsible for almost 50% of the clinical trials conducted globally every year.
Sam Mowers, Investorideas.com
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
800 665 0411